Coligation of the B Cell Receptor with Complement Receptor Type 2 (CR2/CD21) Using Its Natural Ligand C3dg: Activation without Engagement of an Inhibitory Signaling Pathway

Taras Lyubchenko(University of Colorado Health), V. Michael Holers(University of Colorado Health)
The Journal of Immunology
March 1, 2005
Cited by 79


Related Papers